|9 Months Ended|
Sep. 30, 2015
|Warrants and Rights Note Disclosure [Abstract]|
The Company has warrants outstanding to purchase up to 300,000 shares of our common stock at September 30, 2015 and December 31, 2014.
In connection with the sale of the Companys newly designated Series A Convertible Preferred Stock in May 2014, Chardan Capital Markets LLC (Chardan) acted as sole placement agent in consideration for which Chardan received a cash fee of $535,000 and a warrant to purchase up to 300,000 shares of the Companys common stock. These warrants vested immediately, have an exercise price of $2.00 per share, and have a five year term.
The following schedule summarizes the changes in the Companys outstanding warrants during the nine months ended September 30, 2015:
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
Reference 1: http://www.xbrl.org/2003/role/presentationRef